Ben Paterson


Corporate Advisory

Home Our People Ben Paterson


A key dealmaker for Russell McVeagh, with expertise in mergers and acquisitions, private equity transactions, joint ventures and overseas investment. Ben has acted on a number of significant transactions providing high quality legal advice to large scale, high-value corporations on complex financial transactions, including for Pacific Equity Partners, CPE Capital (formerly CHAMP Private Equity), The Riverside Company, Carlyle, Fonterra and Lion. He is trusted and highly valued for his ability to work cooperatively and achieve exceptional and commercially focused results. 

Ben has significant experience in advising receivers and administrators on restructuring and insolvency related M&A, and sponsors on infrastructure projects. He also advises on New Zealand's foreign investment laws, and in 2021 he co-authored the New Zealand chapter of the global publication Getting the Deal Through - Foreign Investment Review 2021 as well as the Chambers and Partners Global Practice Guide 2021 - Private Equity. 


Ben's work highlights include acting for:

  • Fonterra on its $592 million sale of its China dairy farms.
  • Advent International on its acquisition, through its portfolio company Industria Chimica Emiliana, of New Zealand Pharmaceuticals.
  • The founders of Mondiale on the divestment of a 50% stake to Direct Capital. 
  • Fonterra on its $633 million sale of DFE Pharma to CVC.
  • Pacific Equity Partners on its sale of Manuka Health New Zealand.
  • The Riverside Company on its acquisition of the Hiway Group.
  • CPE Capital (formerly CHAMP Private Equity) in respect of a key New Zealand investment.
  • The Carlyle Group on the New Zealand aspects of its acquisition of Accolade Wines.
  • UP Education (a PEP portfolio entity) on its acquisition of NZ Tertiary College.
  • Pacific Equity Partners, on its acquisition of Horizon Global’s Asia Pacific unit.
  • Tahua Capital on the acquisition of Burger King New Zealand.
  • Lion on its acquisition of Havana Coffee.
  • Manuka Health New Zealand on its acquisition of Neuseelandhaus GmbH (a German distributor).
  • Lion on its acquisition of Harrington's Breweries.
  • Lion – Dairy & Drinks on its sale of the Yoplait yoghurt business to Goodman Fielder.
  • The Riverside Company on its sale of Simcro.
  • Lion on its acquisition of Panhead Breweries.
  • Oceania Healthcare on its initial public offering and dual listing on the NZX and ASX.
  • Primavera Capital and Shanghai Pharma on their consortium acquisition (via a scheme of arrangement) of Vitaco Holdings.
  • CDH Fund V on its acquisition of an 80% interest in The Better Health Company (otherwise known as ‘Go Healthy’), a substantial New Zealand manufacturer and distributor of natural extracts and dietary supplements.
  • Pacific Equity Partners on its $700m divestment of Griffin’s Foods to Universal Robina Corporation.
  • Pacific Equity Partners on its acquisition of Manuka Health New Zealand.
  • Daiken on its proposed acquisition of a large Medium Density Fibreboard (MDF) production plant in Mataura (by way of acquisition of shares in Dongwha New Zealand Limited) from Dongwha International and Laminex.
  • Fonterra Co-operative Group on its $342m joint venture with Abbott Laboratories, to develop a hub of five large scale dairy farms in China.
  • Swissport on the New Zealand aspects of its acquisition of Aerocare (an Australian and New Zealand ground handling business).
  • Accor Hotels on the New Zealand aspects of its proposed acquisition of the Mantra Group (by way of scheme of arrangement).
  • A bidder for the Vector Gas transmission and non-Auckland distribution assets.
  • The shareholders of Hally Labels in their divestment of the Hally Labels group to Hexagon Mercury Capital.
  • Newmont Mining Corporation on its US$101m divestment of the Waihi Gold Mine to OceanaGold.
  • Griffin’s Foods Limited on the acquisition of 50.1% of the shares in Proper Snack Foods Limited.
  • Genesis Energy on its $735m IPO.
  • Fonterra Co-operative Group Limited on its establishment of ‘Trading Among Farmers’ including establishing a new private share market operated by NZX Limited, and an initial public offering by the Fonterra Shareholders’ Fund and its listing on both the NZSX and ASX.
  • A bidder for the New Zealand and Australian consumer finance businesses of GE Capital.
  • CITIC on its investment in LanzaTech.
  • Crescent Capital Partners Management and New Zealand Panels Group on the acquisition of the Bestwood and Kopine businesses from Carter Holt Harvey.
  • Oaktree Capital on the restructuring of, and investment in, the Mediaworks Group.
  • Lion on its acquisition of Lindauer and other wine brands from Pernod Ricard.
  • Lion on the buyback of its Newmarket brewery site.
  • The shareholders of Torpedo7 on their sale to The Warehouse.
  • Tyco International on its divestment (to Evergreen Group) of its cash handling and security operations in New Zealand and Fiji.
  • CKI on its $490m acquisition of Envirowaste from Ironbridge.
  • Pacific Equity Partners on its AU$670 million acquisition of 50% of SCA Hygiene Australasia.
  • The administrators of RedGroup on the sale of Whitcoulls and Bennetts.
  • Crescent Capital Partners Management on New Zealand aspects of the dual track IPO/trade sale process for disposal of the National Hearing Care and Bay Audiology group (ultimately divested to Amplifon in 2010 for AU$460m).
  • The receivers on the sale of various assets of the Pumpkin Patch retail group
  • The receivers on the sale of PK Furniture.
  • The receivers on the sale of various assets of the Hurlstone Earthmoving group.
  • The Secure Future Consortium on the Wiri Prison PPP.
  • An underbidder on the Transmission Gully PPP.



LLB (Hons), BSc (University of Canterbury).


Ben is ranked as 'Highly Regarded' in M&A and Private Equity by IFLR1000, recognised by Chambers and Partners 2021 Asia-Pacific and Global guides for Corporate/M&A, a Rising Star by NZ Lawyer, and a 'Leading Individual' by Legal 500, with clients describing Ben as "very hard working, exceptionally diligent, a creative problem solver", a "highly competent deal executor" and an "excellent lawyer. A rising star." Ben is also is recognised in the peer-reviewed Best Lawyers® 2022 guide for Corporate Law. 

Ben is part of our Corporate Advisory team, which has been named New Zealand's top deal firm at the 2019 New Zealand Law Awards


Related Expertise
Related People